$59.04 0.19 (+0.32%)
11/25/2009 4:03 PM

Quest Diagnostics, Inc. (DGX)

CAPS Rating: 4 out of 5

A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.

Results 1 - 20 of 73 1 2 3 4 Next »

Recs

0
Member Avatar 1955Cowboy (33.77) Submitted: 4/3/2008 6:47:59 PM : Outperform Start Price: $46.22 DGX Score: +43.20

Quest Diagnostices has het bottom is is beginning to rebound. this is the prime time to invest.

Recs

0
Member Avatar aaroger (26.87) Submitted: 7/22/2007 5:34:50 PM : Underperform Start Price: $53.01 DGX Score: -35.34

62

Recs

1
Member Avatar aitraders (74.34) Submitted: 1/31/2008 2:26:50 PM : Outperform Start Price: $48.55 DGX Score: +36.84

Exorcised UNH, assimilated Ameripath, mid-year guidance of 6.1 to 6.2 B for 2007 will end up at 6.6/6.7, operating margins are going back up, Ameripath should fuel growth for 2008 and beyond, and now, I've read that the sales reps can now concentrate on new business, instead of keeping old.

Recs

0
Member Avatar ajmccauley (< 20) Submitted: 12/15/2006 9:35:31 PM : Outperform Start Price: $51.35 DGX Score: +32.04

Long-term value play

Recs

0
Member Avatar amckane (76.36) Submitted: 3/31/2009 8:21:21 PM : Underperform Start Price: $46.78 DGX Score: +17.11

Performed relatively well during this bear market. As the market rebounds a bit, DGX won't rebound as fast as it has less "room to run" than many others in the SP500.

Recs

0
Member Avatar anontmp (97.56) Submitted: 8/8/2007 1:43:23 PM : Outperform Start Price: $56.39 DGX Score: +26.16

Quest will continue to grow as out-sourcing of testing will not stop. The stock is a little bit expensive but I expect earnings growth to be better than consensus.

Recs

1
Member Avatar BachHo (85.52) Submitted: 10/6/2006 7:03:40 PM : Outperform Start Price: $49.68 DGX Score: +31.18

Quest lost a major sales outlet 7% of total sales but the company was trying to shed low margin customers and, while large, the lost contract would have been minimal margin

Recs

1
Member Avatar Baseballforever (23.11) Submitted: 4/16/2007 1:57:41 PM : Outperform Start Price: $50.70 DGX Score: +36.11

DGX does medical diagnostics tests. As the baby boomers retire more and more medical diagnostic tests will be done. Furthermore, it is cheaper for insurance companies to do a test and screen early for a disease, ie. cancer, than wait and pay for treatment later. Therefore insurance companies will push more diagnostic tests and push demand. Furthermore, investors are not liking the purchase today of a smaller competitor and have dropped the share price 5% today. As DGX consolidates by eating up competitors it gets stronger in the long term, so I will buy on this dip in price.

Recs

0
Member Avatar bclan13 (99.35) Submitted: 3/11/2009 1:44:59 AM : Outperform Start Price: $44.85 DGX Score: -23.63

Reference labs tend to fair well when cost control comes into play

Recs

0
Member Avatar blissfulone (56.74) Submitted: 5/30/2007 3:28:42 PM : Outperform Start Price: $47.67 DGX Score: +46.90

Seems to be cheap compared to Lab Corp - time will tell.

Recs

0
Member Avatar Budsworth (< 20) Submitted: 4/22/2008 4:59:20 AM : Outperform Start Price: $48.40 DGX Score: +38.39

QUEST DIAGNOSTICS.......,When I hear that name,it hits home like an old familiar tune. This is probably one of the most well managed companies of it's kind. You might look at it as a role model that all the others should pattern themselves after. When all the dust clears from this mess we've put ourselves in, Quest will be outstanding. Great financial history.

Recs

0
Member Avatar burnishedcoppera (< 20) Submitted: 7/9/2008 12:31:05 AM : Outperform Start Price: $48.52 DGX Score: +31.54

With the waxing and waining of winter ailments, this one will rise to the occasion.

Recs

0
Member Avatar buylow45 (49.32) Submitted: 10/21/2009 3:51:48 PM : Outperform Start Price: $56.10 DGX Score: +2.36

The Flu & VRML will make this move higher.

Recs

1
Member Avatar c0ffeen0te (52.08) Submitted: 4/20/2007 2:00:18 PM : Outperform Start Price: $48.98 DGX Score: +40.95

Market has rightly punished price for loss of customer, but valuation seems so low to me that given favorable demographics should be a good long term bet...fwiw, folks in the doctor's office i know greatly prefer their service to that of their competition.

Recs

0
Member Avatar CapableRu (54.36) Submitted: 4/27/2009 7:57:46 PM : Underperform Start Price: $51.45 DGX Score: +17.69

Quest Diagnostics has strength and weakness but it will be interesting to follow through on this time chain.

Recs

0
Member Avatar chiphaynes1962 (27.95) Submitted: 10/20/2006 3:34:21 PM : Outperform Start Price: $50.49 DGX Score: +30.59

Dog Star Theory from Jim Jubak

Recs

0
Member Avatar davion13 (< 20) Submitted: 10/1/2009 9:29:07 AM : Outperform Start Price: $52.00 DGX Score: +7.80

Underperformed the previous quarter and will steadily rise after irrational fear of healthcare legislation subsides

Recs

0
Member Avatar DeepSouthValue (< 20) Submitted: 8/14/2007 9:40:02 AM : Outperform Start Price: $54.04 DGX Score: +28.77

nothing like a monopolistic oligopoly

Recs

0
Member Avatar deltanav (< 20) Submitted: 6/8/2007 3:06:25 PM : Outperform Start Price: $50.52 DGX Score: +38.76

Valuation shows very high returns on capital with or without United Healthcare. Price should improve over time once bad news is digested

Recs

9
Member Avatar dm982 (83.78) Submitted: 10/4/2006 11:53:39 AM : Outperform Start Price: $48.79 DGX Score: +32.71

Baby boomer population is getting old and I expect the lab testing to increase in the future (with Quest being the top dog)...I bought this in early Oct 2006 when there was a major drop in price (over 10%) with the news of the loss of the UnitedHealthcare contract. Hoping I bought low and will reap the benefits.

Results 1 - 20 of 73 1 2 3 4 Next »

Featured Broker Partners